Falls in sales of generic drugs of concern to the sector

The slowing growth of the generic drug market is starting to worry the industry, which recorded its second consecutive monthly downturn in October, according to the Progenéricos, which represents the industry.
In October, with sales revenue fell 5.8 percent compared to September, the month in which there was also a fall of 2.8%, point data from IMS Health.
Despite fluctuations in the monthly results, the recipe for this year until October follows 8.3% higher than in the same period in 2015, without considering the inflation in the period, of 5.8%.
The result is a reflection of the weak economy, not a migration to the sector breakdown, evaluates the President of the Association, Telma Salles.
"The exchange of reference for generic medicines is still high, but the market as a whole if retracted." The sector reached in October to its biggest market share of the year: 31.5% of units sold.
The expiration of patents in the area of Biosimilar is awaited by businesses as one of the factors that could boost the market.
The process, however, suffers from the delay by the INPI (Institute of intellectual property), she says.
"The body needs more efficiently. Are products that could benefit us in the short term, but we don''t know when this forecast will come true. "
Folha de s. Paulo
Towards the outside
Sales of ceramic coatings for the exterior grew 22% between January and October this year in comparison with 2015 points the Anfacer (Industry Association).
Other countries buy today about 13% of the brazilian production and helped reduce losses in 2016, according to the entity.
Pushed by the high of the dollar at the beginning of the year, the group, which had Fragnani fall of 6.1% in revenue between January and October, doubled the volume exported in about 2015.
"Sell m ² 5,100,000 out, almost 15% of our production, says João Ribeiro, Director of the company.
Portobello was discharged from 10% in exports until the third quarter. The variation is less than the initially planned. "The exchange rate fluctuation messed up," says CFO John Suzuki.